Klaritromytsin

Klaritromycin is a macrolide antibiotic used to treat a variety of bacterial infections. It is a semisynthetic derivative of erythromycin, with a modified sugar moiety that enhances its stability and efficacy. The drug works by inhibiting bacterial protein synthesis, specifically targeting the 50S ribosomal subunit. Klaritromycin is effective against a wide range of Gram-positive and Gram-negative bacteria, including Streptococcus, Staphylococcus, and Haemophilus species. It is commonly used to treat respiratory tract infections, skin and soft tissue infections, and urinary tract infections. The drug is available in various formulations, including oral tablets, intravenous injections, and topical creams. Klaritromycin is generally well-tolerated, but like all antibiotics, it can cause side effects such as gastrointestinal upset, allergic reactions, and drug interactions. It is important to use klaritromycin only as directed by a healthcare professional to ensure its effectiveness and minimize the risk of adverse effects.